|
9
|
|
Ultrasound localisation microscopy predicts neoadjuvant chemotherapy response in patients with breast cancer.
(linkinghub.elsevier.com)
|
Porte C
…
Kiessling F
EBioMedicine
2026-08-24
|
#chemotherapy
#breast cancer
#ultrasound
#imaging
#biomarker
|
|
1
|
|
Canonical and non-canonical miRNA degradation shapes state transitions and stemness in breast cancer.
(link.springer.com)
|
Rubolino C
…
Nicassio F
The EMBO Journal
2026-08-17
|
#microrna
#breast cancer
#transcriptomics
#stemness
#drug resistance
|
|
1
|
|
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.
(nature.com)
|
Shao X
…
Ouyang Q
Nature Medicine
2026-08-12
|
#clinical trial
#immunotherapy
#breast cancer
#chemotherapy
|
|
0
|
|
Rb-driven transcription limits its tumour-suppressive effects in breast cancer.
(nature.com)
|
Watt AC
…
Goel S
Nature
2026-08-12
|
#transcriptomics
#breast cancer
#chromatin
#drug resistance
|
|
0
|
|
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
(linkinghub.elsevier.com)
|
Li JJ
…
Zhi-Ming Shao
Cell Reports Medicine
2026-08-06
|
#breast cancer
#precision medicine
#neoadjuvant
#classification
#subtyping
|
|
0
|
|
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
(linkinghub.elsevier.com)
|
Bui TBV
…
Rosenbluth JM
Cell Reports Medicine
2026-08-06
|
#breast cancer
#organoid
#biomarker
#precision medicine
#drug resistance
|
|
0
|
|
Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple negative breast cancer CALGB40603 (Alliance).
(jci.org)
|
Radler PD
…
Perou CM
Journal of Clinical Investigation
2026-08-04
|
#transcriptomics
#breast cancer
#prognosis
#chemotherapy
#immunity
|
|
0
|
|
PBRM1-dependent PBAF targeting is required for EMT and metastasis in breast cancer.
(science.org)
|
Dhiman A
…
Dykhuizen EC
Science Advances
2026-07-29
|
#epigenomics
#metastasis
#emt
#breast cancer
#chromatin
|